Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 20665502)

1.

Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.

Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL.

Cancer. 2010 Nov 15;116(22):5279-89. doi: 10.1002/cncr.25525.

4.

Secondary myelodysplastic syndromes and leukemias.

Giles FJ, Koeffler HP.

Curr Opin Hematol. 1994 Jul;1(4):256-60. Review.

PMID:
9371291
5.

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.

Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S.

J Clin Oncol. 2003 Mar 1;21(5):897-906. Review.

PMID:
12610191
6.

Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).

Ogasawara T, Yasuyama M, Kawauchi K.

Am J Hematol. 2005 Jun;79(2):136-41. Review.

PMID:
15929101
7.

Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.

Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.

J Clin Oncol. 2010 Jun 10;28(17):2914-24. doi: 10.1200/JCO.2009.25.8723. Epub 2010 Apr 12. Review.

PMID:
20385991
8.

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.

Borthakur G, Estey AE.

Curr Oncol Rep. 2007 Sep;9(5):373-7. Review.

PMID:
17706165
9.

Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.

Freedman MH, Alter BP.

Semin Hematol. 2002 Apr;39(2):128-33. Review.

PMID:
11957196
10.

[Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents].

Abrahamsen AF.

Tidsskr Nor Laegeforen. 2000 Sep 10;120(21):2542-5. Review. Norwegian.

PMID:
11070993
11.

Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.

Deschler B, de Witte T, Mertelsmann R, L├╝bbert M.

Haematologica. 2006 Nov;91(11):1513-22. Review.

12.

Acute myelogenous leukemia and myelodysplasia secondary to breast cancer treatment: case studies and literature review.

Cole M, Strair R.

Am J Med Sci. 2010 Jan;339(1):36-40. doi: 10.1097/MAJ.0b013e3181bedb74. Review.

PMID:
19996729
13.

Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.

Smith MA, Rubinstein L, Ungerleider RS.

Med Pediatr Oncol. 1994;23(2):86-98. Review.

PMID:
8202047
14.

Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.

Lyman GH, Kuderer NM.

Cancer Treat Res. 2011;157:167-78. doi: 10.1007/978-1-4419-7073-2_10. Review. No abstract available.

PMID:
21052956
15.
16.

The role of myelopoietic growth factors in managing cancer in the elderly.

Balducci L, Carreca I.

Drugs. 2002;62 Suppl 1:47-63. Review.

PMID:
12479594
17.

Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?

Hake CR, Graubert TA, Fenske TS.

Bone Marrow Transplant. 2007 Jan;39(2):59-70. Epub 2006 Dec 4. Review.

PMID:
17143301
18.

Benzene and human health: A historical review and appraisal of associations with various diseases.

Galbraith D, Gross SA, Paustenbach D.

Crit Rev Toxicol. 2010 Nov;40 Suppl 2:1-46. doi: 10.3109/10408444.2010.508162. Review.

PMID:
20939751
19.

Myelodysplastic syndromes: the challenge of developing clinical guidelines and supportive care strategies for a rare disease.

Kurtin SE.

Clin J Oncol Nurs. 2012 Jun;16 Suppl:5-7. doi: 10.1188/12.CJON.S1.5-7. Review.

20.

[Therapeutic policy for malignant lymphoma of the aged].

Kitamura K.

Nihon Naika Gakkai Zasshi. 2001 Jun 10;90(6):1010-8. Review. Japanese. No abstract available.

PMID:
11460365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk